PMID- 17651427 OWN - NLM STAT- MEDLINE DCOM- 20071017 LR - 20220309 IS - 0953-816X (Print) IS - 0953-816X (Linking) VI - 26 IP - 3 DP - 2007 Aug TI - A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. PG - 757-66 AB - The medial prefrontal cortex (mPFC) is critical for reinstatement of cocaine seeking and is the main source of brain-derived neurotrophic factor (BDNF) to striatal regions of the brain relapse circuitry. To test the hypothesis that BDNF in the mPFC regulates cocaine-seeking behavior, rats were trained to press a lever for cocaine infusions (0.2 mg/inf, 2 h/day) paired with light+tone conditioned stimulus (CS) presentations on 10 consecutive days. After the last self-administration session, rats received a single infusion of BDNF (0.75 microg/0.5 microL/side) into the mPFC; this manipulation produced protracted effects on cocaine-seeking behavior (non-reinforced lever pressing). BDNF pretreatment administered after the last session attenuated cocaine seeking 22 h later and, remarkably, it also blocked cocaine-induced suppression of phospho-extracellular-regulated kinase and elevated BDNF immunoreactivity in the nucleus accumbens. The same pretreatment also suppressed cocaine-seeking behavior elicited by response-contingent CS presentations after 6 days of forced abstinence or extinction training, as well as a cocaine challenge injection (10 mg/kg, i.p.) after extinction training. However, BDNF infused into the mPFC had no effect on food-seeking behavior. Furthermore, BDNF infused on the sixth day of abstinence failed to alter responding, suggesting that the regulatory influence of BDNF is time limited. The suppressive effects of BDNF infused into the mPFC on cocaine seeking indicate that BDNF regulates cortical pathways implicated in relapse to drug seeking and that corticostriatal BDNF adaptations during early abstinence diminish compulsive drug seeking. FAU - Berglind, William J AU - Berglind WJ AD - Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA. FAU - See, Ronald E AU - See RE FAU - Fuchs, Rita A AU - Fuchs RA FAU - Ghee, Shannon M AU - Ghee SM FAU - Whitfield, Timothy W Jr AU - Whitfield TW Jr FAU - Miller, Scott W AU - Miller SW FAU - McGinty, Jacqueline F AU - McGinty JF LA - eng GR - C06 RR015455/RR/NCRR NIH HHS/United States GR - P50 DA15369/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20070725 PL - France TA - Eur J Neurosci JT - The European journal of neuroscience JID - 8918110 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Dopamine Uptake Inhibitors) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - I5Y540LHVR (Cocaine) SB - IM MH - Animals MH - Behavior, Animal/drug effects/physiology MH - Brain-Derived Neurotrophic Factor/administration & dosage/*pharmacology MH - Cocaine/*adverse effects MH - Cocaine-Related Disorders/drug therapy/*metabolism/physiopathology MH - Conditioning, Psychological/drug effects/physiology MH - Dopamine Uptake Inhibitors/adverse effects MH - Drug Administration Routes MH - Extracellular Signal-Regulated MAP Kinases/drug effects/metabolism MH - Male MH - Neural Pathways/drug effects/metabolism/physiopathology MH - Nucleus Accumbens/drug effects/metabolism/physiopathology MH - Prefrontal Cortex/*drug effects/*metabolism/physiopathology MH - Rats MH - Rats, Sprague-Dawley MH - Secondary Prevention MH - Self Administration MH - Substance Withdrawal Syndrome/drug therapy/*metabolism/physiopathology MH - Time Factors EDAT- 2007/07/27 09:00 MHDA- 2007/10/18 09:00 CRDT- 2007/07/27 09:00 PHST- 2007/07/27 09:00 [pubmed] PHST- 2007/10/18 09:00 [medline] PHST- 2007/07/27 09:00 [entrez] AID - EJN5692 [pii] AID - 10.1111/j.1460-9568.2007.05692.x [doi] PST - ppublish SO - Eur J Neurosci. 2007 Aug;26(3):757-66. doi: 10.1111/j.1460-9568.2007.05692.x. Epub 2007 Jul 25.